Profile

Timothy E.  Kute, Ph.D.

Timothy E. Kute, Ph.D.

Associate Professor, Pathology-Tumor Biology
Contact Information
Office:
336-716-2950
Clinical Specialties
Metastatic Disease, Mechanisms of Hormone Therapy, Molecular Diagnosis, Flow Cytometry, Steroid Receptor Analysis, Breast Cancer Characterization, Proteases
Education & Training
  BSUniversity of Cincinnati1967
  PhDUniversity of Louisville School of Medicine1975
FellowshipU Rochester Affil Hosps1976
Memberships
American Association of Cancer Research
British Medical Assn
Canadian Association of General Surgeons
Timothy E.  Kute, Ph.D.

Timothy E. Kute, Ph.D.

Associate Professor, Pathology-Tumor Biology
Contact Information
Office:
336-716-2950
Recent Publications
Clausen KA, Blish KR, Birse CE, Triplette MA, Kute TE, Russell GB, D'Agostino RB Jr, Miller LD, Torti FM, Torti SV. SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer. Breast Cancer Res Treat. 2011; 129(3):737-746.


Smyre CL, Saluta G, Kute TE, Kucera GL, Bierbach U. Inhibition of DNA synthesis by a platinum-acridine hybrid agent leads to potent cell kill in nonsmall cell lung cancer. ACS Med Chem Lett. 2011; 2(11):870-874.


Conner-Kerr T, Alston G, Stovall A, Vernon T, Winter D, Meixner J, Grant K, Kute T. The effects of low-frequency ultrasound (35 kHz) on methicillin-resistant Staphylococcus aureus (MRSA) in vitro. Ostomy Wound Manage. 2010; 56(5):32-42.


Pinnix ZK, Miller LD, Wang W, D'Agostino R Jr, Kute T, Willingham MC, Hatcher H, Tesfay L, Sui G, Di X, Torti SV, Torti FM. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med. 2010; 2(43):43ra56.


Kute TE, Savage L, Stehle JR Jr, Kim-Shapiro JW, Blanks MJ, Wood J, Vaughn JP. Breast tumor cells isolated from in vitro resistance to trastuzumab remain sensitive to trastuzumab anti-tumor effects in vivo and to ADCC killing. Cancer Immunol Immunother. 2009; 58(11):1887-1896.


Winter JL, Stackhouse BL, Russell GB, Kute TE. Measurement of PTEN expression using tissue microarrays to determine a race-specific prognostic marker in breast cancer. Arch Pathol Lab Med. 2007; 131(5):767-772.


Kute TE, Savage L, Wood J, Vaughn J. Mechanism of action of herceptin killing of HER-2+breast cancer cells under 'in vitro' and 'in vivo' conditions [abstract]. Breast Cancer Res Treat. 2007; 106(Suppl 1):S123.


Shackleford TJ, Korapati A, Le XF, Kute T, Rassidakis G. JAB1 confers resistance to trastuzumab by inhibition of p27 [abstract]. Mol Cancer Ther. 2007; 6(12 Pt 2):3473-74S.
All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Last Updated 1/19/2012
Loading...
Quick Reference
Request an Appointment
New Patients
336-716-WAKE
888-716-WAKE
Existing patients may contact the clinic directly.
Locate Faculty

e.g., "allergy," "diabetes"

US News Best Hospital AwardANCC Magnet Association AwardBest Doctors 2011-2012 AwardThe Joint Commission National Quality ApprovalConsumer Choice #1 Award 2011-2102US News Best Medical Schools 2011 Award
Loading...

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.